Northern Trust Corp Immunovant, Inc. Transaction History

Northern Trust Corp

  • $600 Billion
  • Q3 2024

A detailed history of Northern Trust Corp transactions in Immunovant, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 506,990 shares of IMVT stock, worth $13.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
506,990
Previous 463,721 9.33%
Holding current value
$13.9 Million
Previous $12.2 Million 13.93%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$27.51 - $27.51 $1.19 Million - $1.19 Million
43,269 Added 9.33%
506,990 $13.9 Million
Q2 2024

Aug 14, 2024
SELL
$25.1 - $31.61 $376,148 - $473,707
-14,986 Reduced 3.13%
463,721 $12.2 Million
Q1 2024

May 14, 2024
SELL
$30.27 - $43.79 $483,926 - $700,070
-15,987 Reduced 3.23%
478,707 $15.5 Million
Q4 2023

Feb 13, 2024
BUY
$31.31 - $44.19 $479,857 - $677,255
15,326 Added 3.2%
494,694 $20.8 Million
Q3 2023

Nov 13, 2023
SELL
$18.55 - $39.96 $250,276 - $539,140
-13,492 Reduced 2.74%
479,368 $18.4 Million
Q2 2023

Aug 11, 2023
BUY
$14.2 - $23.75 $1.16 Million - $1.94 Million
81,813 Added 19.9%
492,860 $9.35 Million
Q1 2023

May 15, 2023
SELL
$15.27 - $19.72 $105,301 - $135,989
-6,896 Reduced 1.65%
411,047 $6.38 Million
Q4 2022

Feb 13, 2023
BUY
$6.59 - $17.75 $448,568 - $1.21 Million
68,068 Added 19.45%
417,943 $7.42 Million
Q3 2022

Nov 14, 2022
SELL
$3.93 - $6.37 $28,948 - $46,921
-7,366 Reduced 2.06%
349,875 $1.95 Million
Q2 2022

Aug 12, 2022
SELL
$3.38 - $5.65 $38,008 - $63,534
-11,245 Reduced 3.05%
357,241 $1.39 Million
Q1 2022

May 13, 2022
SELL
$5.06 - $8.77 $105,804 - $183,380
-20,910 Reduced 5.37%
368,486 $2.03 Million
Q4 2021

Feb 08, 2022
SELL
$7.33 - $9.32 $12,087 - $15,368
-1,649 Reduced 0.42%
389,396 $3.32 Million
Q3 2021

Nov 15, 2021
SELL
$7.01 - $11.37 $184,117 - $298,633
-26,265 Reduced 6.29%
391,045 $3.4 Million
Q2 2021

Aug 13, 2021
SELL
$9.4 - $16.85 $304,005 - $544,945
-32,341 Reduced 7.19%
417,310 $4.41 Million
Q1 2021

May 12, 2021
SELL
$13.08 - $49.6 $224,805 - $852,475
-17,187 Reduced 3.68%
449,651 $7.21 Million
Q4 2020

Feb 11, 2021
BUY
$36.36 - $52.71 $1.37 Million - $1.99 Million
37,807 Added 8.81%
466,838 $21.6 Million
Q3 2020

Nov 16, 2020
BUY
$22.61 - $38.9 $3.52 Million - $6.06 Million
155,699 Added 56.96%
429,031 $15.1 Million
Q2 2020

Aug 14, 2020
BUY
$13.87 - $28.44 $3.49 Million - $7.16 Million
251,701 Added 1163.61%
273,332 $6.66 Million
Q1 2020

May 14, 2020
SELL
$8.36 - $17.13 $16,243 - $33,283
-1,943 Reduced 8.24%
21,631 $337,000
Q4 2019

Feb 14, 2020
BUY
$10.02 - $16.4 $236,211 - $386,613
23,574 New
23,574 $374,000

Others Institutions Holding IMVT

# of Institutions
211
Shares Held
66.9M
Call Options Held
2.3M
Put Options Held
631K
View Full List

About Immunovant, Inc.

IMVT Quotes by TradingView
  • Ticker IMVT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 129,077,000
  • Market Cap $3.55B
  • Description
  • Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, which is in Phase IIa clinical trials for the treatment of mya...
More about IMVT
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email